Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Total revenues | revenue | 752.95M | 7.12% |
| Equity income (loss) from unconsolidated joint ventures | revenue | 4.26M | 98.65% |
| Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures | profit | 195.65M | 260.36% |
| Total costs and expenses | cost | 747.35M | 16.32% |
| Impairments and loan loss reserves (recoveries), net | cost | 2.27M | -36.13% |
| Aggregate | revenue | 199.91M | -69.06% |
| Aggregate | cost | 749.63M | 16.04% |
| Net income (loss) | profit | 199.66M | 298.80% |
| Income tax expense (benefit) | cost | 254000 | -87.79% |
| Operating | cost | 323.86M | 18.57% |
| Depreciation, depletion and amortization, nonproduction | cost | 289.73M | 7.89% |
| Interest expense | cost | 87.29M | 20.08% |
| General and administrative | cost | 24.59M | -5.85% |
| Transaction costs | cost | 24.15M | 336.38% |
| Net income (loss) attributable to healthpeak properties, inc. | profit | 193.63M | 352.12% |
| Income (loss) from continuing operations, net of tax, attributable to noncontrolling interest | cost | 6.02M | -16.76% |
| Net income (loss) applicable to common shares | profit | 193.48M | 356.72% |
| Participating securities, distributed and undistributed earnings (loss), basic | cost | 149000 | -67.89% |
| Segment | Value | YoY |
|---|---|---|
| Outpatient Medical | 318.22M | 1.20% |
| Lab | 212.81M | -2.20% |
| Senior Housing | 200.34M | 34.53% |
| Others | 21.58M | -1.52% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Buildings and improvements | assets | 17.17B | |
| Land and improvements | assets | 3.22B | |
| Development costs and construction in progress | assets | 1.06B | |
| Aggregate | assets | 21.45B | |
| Net real estate | assets | 16.84B | |
| Real estate investment property, accumulated depreciation | assets | 4.61B | |
| Cash and cash equivalents | assets | 1.17B | |
| Other assets | assets | 871.11M | |
| Intangible assets | assets | 758.50M | |
| Loans receivable, net of reserves of $9,290 and $11,345 | assets | 631.65M | |
| Investments in unconsolidated joint ventures | assets | 530.35M | |
| Right-of-use asset | assets | 395.93M | |
| Deferred tax assets | assets | 120.31M | |
| Restricted cash | assets | 94.92M | |
| Accounts receivable, net | assets | 91.47M | |
| Goodwill | assets | 68.53M | |
| Assets held for sale | assets | 45.67M | |
| Total assets | assets | 21.62B | |
| Total liabilities | liabilities | 12.56B | |
| Total equity | liabilities | 9.03B | |
| Redeemable noncontrolling interests | liabilities | 27.21M | |
| Senior unsecured notes | liabilities | 6.78B | |
| Bank line of credit and commercial paper | liabilities | 1.75B | |
| Term loans | liabilities | 1.65B | |
| Deferred revenue | liabilities | 1.01B | |
| Accounts payable, accrued liabilities, and other liabilities | liabilities | 671.25M | |
| Lease liability | liabilities | 290.09M | |
| Mortgage debt | liabilities | 246.46M | |
| Intangible liabilities | liabilities | 164.36M | |
| Liabilities related to assets held for sale | liabilities | 545000 | |
| Total noncontrolling interests | liabilities | 1.21B | |
| Accumulated distributions in excess of net income | equity | 5.97B | |
| Accumulated other comprehensive income (loss) | equity | 464000 | |
| Total stockholders’ equity | equity | 7.83B | |
| Public investors of janus living, inc. | liabilities | 560.43M | |
| Non-managing member unitholders | liabilities | 351.79M | |
| Joint venture partners | liabilities | 294.30M | |
| Aggregate | equity | 13.80B | |
| Additional paid-in capital | equity | 13.10B | |
| Common stock, value, issued | equity | 695.26M |
| Item | Value |
|---|---|
| Depreciation and amortization of real estate, in-place lease, and other intangibles | 289.73M |
| Net income (loss) | 199.66M |
| Increase (decrease) in deferred revenue | 36.96M |
| Amortization of deferred financing costs and debt discounts (premiums) | 8.36M |
| Stock-based compensation issued as part of initial public offering of janus living, inc. | 4.87M |
| Stock-based compensation amortization expense | 4.50M |
| Increase (decrease) in accounts receivable and other operating assets | 890000 |
| Gain (loss) on debt extinguishments | 403000 |
| Distributions of earnings from unconsolidated joint ventures | 251000 |
| Insured event, gain (loss) | -190000 |
| Deferred income tax expense (benefit) | -1.09M |
| Asset impairment charges | -2.27M |
| Other noncash income (expense) | -2.74M |
| Income loss from equity method investments, including discontinued operations | -4.26M |
| Amortization of above (below) market lease intangibles | -6.60M |
| Straight line rent | -10.90M |
| Amortization of non-refundable entrance fees | -27.20M |
| Increase (decrease) in accounts payable, accrued liabilities, and other liabilities | -40.71M |
| Gain (loss) on sale of investments | -50.67M |
| Gain (loss) from change of control | -138.12M |
| Item | Value |
|---|---|
| Proceeds from the bx jv i and ii transaction, net | 162.80M |
| Proceeds from sales of real estate, net | 90.36M |
| Distributions in excess of earnings from unconsolidated joint ventures | 8.87M |
| Proceeds from insurance recovery | 6.84M |
| Proceeds from principal repayment, loan and lease, held-for-investment | 5.04M |
| Payments to acquire interest in subsidiaries and affiliates | -1.17M |
| Payments for leasing costs, commissions, and tenant improvements | -23.96M |
| Payments to acquire loans receivable and other | -26.06M |
| Payments to develop real estate assets | -142.13M |
| Cash paid | -291.35M |
| Payments to acquire other real estate | -427.85M |
| Item | Value |
|---|---|
| Borrowings under bank line of credit and commercial paper | 5.89B |
| Proceeds from janus living initial public offering, net of underwriting fees | 901.33M |
| Issuance of common stock, net of offering costs | 97000 |
| Payments for repurchase of common stock | -1.37M |
| Payment for debt extinguishment or debt prepayment cost | -3.74M |
| Payments for noncontrolling interest issuance costs | -6.96M |
| Repayments of bank debt | -102.23M |
| Payments to noncontrolling interests | -141.75M |
| Payments of dividends | -211.99M |
| Repayments of lines of credit | -5.22B |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 537.70M |
| Cash and cash equivalents, end of period | 1.27B |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support